Labiana Health S.A [LAB] vs Almirall S.A [ALM] Detailed Stock Comparison

Labiana Health S.A.

BME
Loading...

Almirall S.A.

BME
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Labiana Health S.A. wins in 13 metrics, Almirall S.A. wins in 6 metrics, with 0 ties. Labiana Health S.A. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Labiana Health S.A. Almirall S.A. Better
P/E Ratio (TTM) 42.50 58.64 Labiana Health S.A.
Price-to-Book Ratio 7.81 1.86 Almirall S.A.
Debt-to-Equity Ratio 998.21 23.30 Almirall S.A.
PEG Ratio 6.04 23.08 Labiana Health S.A.
EV/EBITDA 7.09 13.48 Labiana Health S.A.
Profit Margin (TTM) 1.26% 4.14% Almirall S.A.
Operating Margin (TTM) 13.02% 1.97% Labiana Health S.A.
EBITDA Margin (TTM) 13.02% 1.97% Labiana Health S.A.
Return on Equity 23.11% 3.10% Labiana Health S.A.
Return on Assets (TTM) 7.43% 1.90% Labiana Health S.A.
Free Cash Flow (TTM) $4.15M $37.15M Almirall S.A.
Dividend Yield N/A 1.67% N/A
1-Year Return 122.04% 31.68% Labiana Health S.A.
Price-to-Sales Ratio (TTM) 0.60 2.48 Labiana Health S.A.
Enterprise Value $66.57M $2.74B Almirall S.A.
EV/Revenue Ratio 0.93 2.46 Labiana Health S.A.
Gross Profit Margin (TTM) 147.79% 78.50% Labiana Health S.A.
Revenue per Share (TTM) $10 $5 Labiana Health S.A.
Earnings per Share (Diluted) $0.12 $0.22 Almirall S.A.
Beta (Stock Volatility) -0.30 0.19 Labiana Health S.A.

Labiana Health S.A. vs Almirall S.A. Stock Performance Analysis

Loading Price Chart...

LAB
ALM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Labiana Health S.A.16.38%37.20%27.36%54.11%60.71%37.76%
Almirall S.A.-0.93%-0.47%11.78%-0.16%0.79%-1.40%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Labiana Health S.A.122.04%125.00%9,542.86%743.75%743.75%743.75%
Almirall S.A.31.68%36.63%-2.60%-9.40%65.19%-15.31%

Performance & Financial Health Analysis: Labiana Health S.A. vs Almirall S.A.

MetricLABALM
Market Information
Market Cap i€49.24M€2.76B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i10,525140,818
90 Day Avg. Volume i12,584142,299
Last Close€6.75€12.72
52 Week Range€2.80 - €6.95€9.41 - €13.98
% from 52W High-2.88%-9.01%
All-Time High€6.95 (Apr 24, 2026)€19.09 (Dec 28, 2015)
% from All-Time High-2.88%-33.37%
Growth Metrics
Quarterly Revenue Growth0.12%0.11%
Quarterly Earnings Growth0.55%1.39%
Financial Health
Profit Margin (TTM) i0.01%0.04%
Operating Margin (TTM) i0.13%0.02%
Return on Equity (TTM) i0.23%0.03%
Debt to Equity (MRQ) i998.2123.30
Cash & Liquidity
Book Value per Share (MRQ)€0.65€6.92
Cash per Share (MRQ)€0.54€1.58
Operating Cash Flow (TTM) i€3.18M€174.46M
Levered Free Cash Flow (TTM) i€642,357€34.95M
Dividends
Last 12-Month Dividend Yield iN/A1.67%
Last 12-Month Dividend iN/A€0.18

Valuation & Enterprise Metrics Analysis: Labiana Health S.A. vs Almirall S.A.

MetricLAB (Apr 24, 2026)ALM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i42.5058.64
Forward P/E i6.0423.08
PEG Ratio i6.0423.08
Price to Sales (TTM) i0.602.48
Price to Book (MRQ) i7.811.86
Market Capitalization
Market Capitalization i€49.24M€2.76B
Enterprise Value i€66.57M€2.74B
Enterprise Value Metrics
Enterprise to Revenue i0.932.46
Enterprise to EBITDA i7.0913.48
Risk & Other Metrics
Beta i-0.300.19
Book Value per Share (MRQ) i€0.65€6.92

Financial Statements Comparison: Labiana Health S.A. vs Almirall S.A.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricLAB (2024)ALM (2025)
Revenue/Sales i66.26M1.11B
Cost of Goods Sold i25.31M236.47M
COGS % of Revenue i38.2%21.3%
Gross Profit i40.94M871.61M
Gross Margin i61.8%78.7%
Research & Development iN/A96.00M
Operating Income (EBIT) i5.10M66.75M
Operating Margin i7.7%6.0%
EBITDA i9.31M221.67M
EBITDA Margin i14.0%20.0%
Pre-Tax Income i-29,99774.45M
Pre-Tax Income % of Revenue i0.0%6.7%
Income Tax i-236,50228.29M
Income Tax % of Revenue i-0.4%2.6%
Net Income (Profit) i206,50546.15M
Profit Margin i0.3%4.2%

Balance Sheet & Liquidity Metrics

MetricLAB (2024)ALM (2025)
Cash & Equivalents i6.74M337.77M
Total Current Assets i28.70M713.98M
Total Current Assets % of Revenue i43.3%64.4%
Total Current Liabilities i22.16M350.64M
Total Current Liabilities % of Revenue i33.4%31.6%
Long-Term Debt i27.24M324.81M
Long-Term Debt % of Revenue i41.1%29.3%
Total Shareholders Equity i2.57M1.49B
Retained Earnings i253,44946.15M
Retained Earnings % of Revenue i0.4%4.2%
Property, Plant & Equipment i1.27M15.87M

Cash Flow Statement Comparison

MetricLAB (2024)ALM (2025)
Operating Cash Flow i5.46M60.83M
Operating Cash Flow % of Revenue i8.2%5.5%
Capital Expenditures i-3.01M-34.91M
Free Cash Flow i4.15M37.15M
FCF Margin i6.3%3.4%
Debt Repayment i-3.64M-10.00M
Common Stock Repurchase i-158,929N/A

Short Interest & Institutional Ownership Analysis

MetricLABALM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i7.22M214.63M
Float Shares iN/A75.35M
% Held by Insiders i61.15%64.96%
% Held by Institutions i0.49%18.17%
% Held by Public i38.36%16.87%

Dividend Analysis & Yield Comparison: Labiana Health S.A. vs Almirall S.A.

MetricLABALM
Last 12-Month Dividend iN/A€0.18
Last 12-Month Dividend Yield iN/A1.67%
3-Year Avg Annual Dividend iN/A€0.18
3-Year Avg Dividend Yield iN/A1.97%
3-Year Total Dividends iN/A€0.54
Ex-Dividend DateN/AMay 15, 2025